CELEBREX is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by H.j. Harkins Company, Inc.. The primary component is Celecoxib.
Product ID | 52959-540_fa8f4605-2a86-49f2-8a42-d706ce01a5b0 |
NDC | 52959-540 |
Product Type | Human Prescription Drug |
Proprietary Name | CELEBREX |
Generic Name | Celecoxib |
Dosage Form | Capsule |
Route of Administration | ORAL |
Marketing Start Date | 1998-10-02 |
Marketing Category | NDA / NDA |
Application Number | NDA020998 |
Labeler Name | H.J. Harkins Company, Inc. |
Substance Name | CELECOXIB |
Active Ingredient Strength | 100 mg/1 |
Pharm Classes | Cyclooxygenase Inhibitors [MoA],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 1998-10-02 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Marketing Category | NDA |
Application Number | NDA020998 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1998-10-02 |
Inactivation Date | 2019-11-13 |
Ingredient | Strength |
---|---|
CELECOXIB | 100 mg/1 |
SPL SET ID: | b6bd0101-ebf0-43e8-99bf-21cb032b05d6 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
0025-1515 | CELEBREX | Celecoxib |
0025-1520 | CELEBREX | Celecoxib |
0025-1525 | CELEBREX | Celecoxib |
0025-1530 | CELEBREX | Celecoxib |
68387-552 | CELEBREX | CELEBREX |
68788-0768 | CELEBREX | CELEBREX |
21695-023 | CELEBREX | CELEBREX |
21695-022 | CELEBREX | CELEBREX |
33261-019 | CELEBREX | CELEBREX |
49999-383 | CELEBREX | CELEBREX |
52959-540 | CELEBREX | CELEBREX |
52959-539 | CELEBREX | CELEBREX |
55154-3621 | CELEBREX | CELEBREX |
55154-3622 | CELEBREX | CELEBREX |
55289-451 | CELEBREX | CELEBREX |
55154-3625 | CELEBREX | CELEBREX |
55289-475 | CELEBREX | CELEBREX |
61919-046 | CELEBREX | CELEBREX |
63187-079 | CELEBREX | CELEBREX |
63629-6368 | CELEBREX | CELEBREX |
63629-3021 | CELEBREX | CELEBREX |
66336-940 | CELEBREX | CELEBREX |
67544-204 | CELEBREX | CELEBREX |
80425-0096 | Celebrex | Celebrex |
80425-0038 | Celebrex | Celebrex |
80425-0040 | Celebrex | Celebrex |
80425-0037 | Celebrex | Celebrex |
80425-0039 | Celebrex | Celebrex |
0093-7165 | Celecoxib | Celecoxib |
0093-7166 | Celecoxib | Celecoxib |
0093-7170 | Celecoxib | Celecoxib |
0093-7306 | Celecoxib | Celecoxib |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CELEBREX 88814821 not registered Live/Pending |
G. D. Searle LLC 2020-02-28 |
CELEBREX 75655826 2321622 Live/Registered |
G. D. SEARLE LLC 1999-03-08 |
CELEBREX 75432043 2307888 Live/Registered |
G. D. SEARLE LLC 1998-02-10 |